GenomOncology was founded in 2012 knowing that the promise of precision oncology was being held back by fragmented data systems, manual workflows, and a lack of integrated decision support tools.
What began as a vision to create the “operating system” for precision oncology has evolved into a comprehensive platform serving 50+ leading institutions across molecular pathology, clinical trials, research, and data enablement.
Today, GenomOncology stands at the forefront of precision oncology technology, trusted by molecular pathologists, clinical oncologists, researchers, and health system leaders to power their most critical decisions.




